Navigation Links
Repligen Reports Second Quarter Fiscal Year 2011 Financial Results
Date:11/2/2010

ORPORATIONSTATEMENTS OF OPERATIONS(Unaudited) Three months ended September 30, Six months ended September 30, 2010200920102009Revenue:Product revenue

$
4,415,786 $
2,741,578 $
8,684,598 $
5,214,168 Royalty and other revenue2,891,192 2,679,016 5,632,252 5,267,279 Total revenue7,306,978 5,420,594 4,316,850 ,481,447 Operating expenses:Cost of product revenue,471,561 918,464 2,737,311 2,188,938 Cost of royalty and other revenue376,991 341,057 748,733 58,803 Research and development3,119,279 3,478,845 5,814,327 ,861,845 Selling, general and administrative,812,617 ,888,619 3,600,854 3,405,975 Total operating expenses,780,448 ,626,985 2,901,225 3,115,561 Income (loss) from operations526,530 (1,206,391),415,625 (2,634,114)Investment income96,679 227,364 95,637 549,783 Interest expense-   (676)- (1,352)Income (loss) before income taxes23,209 (979,703),611,262 (2,085,683)Income tax (benefit) provision-   -   -   -   Net income (loss)

$
23,209 $
(979,703) $
,611,262 $
(2,085,683)Earnings (loss) per share:Basic

$
.02 $
(0.03) $
.05 $
(0.07)Diluted

$
.02 $
(0.03) $
.05 $
(0.07)Weighted average shares outstanding:Basic30,780,279 30,745,691 30,773,967 30,743,961 Diluted30,920,400 30,745,691 30,922,474 30,743,961 Balance Sheet Data:

September 30, 2010March 31, 2010Cash, cash equivalents and marketable securities*

$
59,691,183 $
59,146,447 Working capital,551,729 55,023,895 Total assets72,627,865 71,419,963 Long-term obligations20,149 42,447 Accumulated deficit(116,309,843)(117,921,105)Stockholders' equity8,262,408 ,120,376 *does not include restricted cashThis press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not const
'/>"/>

SOURCE Repligen Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Repligen Receives Research Grants to Support Friedreichs Ataxia Development Program
2. Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model
3. Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT
4. Repligen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference Monday, November 10th, 4:55 p.m. EST
5. Repligen Announces Conference Call of Third Quarter Fiscal Year 2009 Results
6. Repligen to Present at the BIO CEO & Investor Conference Monday, February 9th, 11:30 a.m. EST
7. Repligen Reports Third Quarter Fiscal Year 2009 Financial Results
8. Repligen to Present at the Cowen and Company 29th Annual Healthcare Conference Monday, March 16th, 2:25 p.m. EDT
9. Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2009 Results
10. Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results
11. Repligen Announces Conference Call of First Quarter Fiscal Year 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 22, 2013 Genedata, a leading ... drug discovery, and life science research, today announced ... as its bioinformatics platform for strain genome ... will provide AB Enzymes, one of the world’s ... solution of Genedata Selector accompanied by bioinformatics consulting ...
(Date:5/22/2013)... New York, NY (PRWEB) May 22, 2013 ... My Cleaning Products said that there is a way to ... victims, it included on its latest post the details of ... spending too much money. , Mold could be prevented, My ... preventive measures, the company stated that a mold remediation must ...
(Date:5/22/2013)... West Chester, PA (PRWEB) May 22, 2013 ... the company as Fermentation Manager. Mr. McErlean has ... a variety of leadership positions throughout his career. ... stated, “We are very pleased to have Mike join ... our newly installed large scale fermentation and ...
(Date:5/22/2013)...  Moderna Therapeutics, the pioneering company developing messenger RNA ... in vivo production of therapeutic proteins, announced ... join Moderna in early July as its first Chief ... leader in the design and implementation of information systems ... translation, clinical operations and commercial preparedness. John has also ...
Breaking Biology Technology:AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4How to Kill Mold While Saving Thousands of Dollars on Mold Remediation Projects Explained by My Cleaning Products 2Envera Appoints Michael McErlean Fermentation Manager 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3
... A delegation led by Governor Doyle and organized by ... the biotechnology industrys leading conference with goals to establish ... and university community and to let others know that ... of the group, the delegation met its objectives in ...
... companies who dont panic, that will continue to grow and ... working on a project for the Council for Continuous Improvement ... was arranging and conducting seminars for executives in the auto ... make or break situation with many quality control issues. During ...
... GE Medical Systems, a unit of General Electric Company, ... U.S. Food and Drug Administration to begin marketing its ... The Signa EXCITE 3.0T combines the increased speed and ... breadth of imaging capabilities found on premium 1.5 Tesla ...
Cached Biology Technology:On site at BIO 2003 2On site at BIO 2003 3On site at BIO 2003 4On site at BIO 2003 5A Race without a Finish Line! 2GE Medical Systems Receives FDA Clearance for New MRI System 2
(Date:5/21/2013)... researchers have developed a new method for delivering ... in the cell surface. The technique could find ... biological fields. , Bulk electroporation a technique ... nanopores in the cell membrane that are caused ... an increasingly popular method of cell transfection. (Cell ...
(Date:5/21/2013)... keeping in shape is an uphill battle? Try staying ... prolonged weightlessness withers muscle and bone. , That,s the ... address with a new three-year, $1.2 million grant from ... exercise during multiyear exploratory missions. , "You could give ... you can,t get them to stick to it, it ...
(Date:5/21/2013)... 2013 Royal Philips Electronics (NYSE: PHG, AEX: ... portable ultrasound with Philips, industry leading Live 3D TEE, ... xMATRIX with available Live 3D TEE and ICE will ... the EuroPCR, official meeting for the European Association of ... its launch in 2012, Philips CX50 xMATRIX has been ...
Breaking Biology News(10 mins):Single-cell transfection tool enables added control for biological studies 2Fueling fitness on the final frontier 2Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2
... 16, 2010 (Toronto) New research from the Centre ... Sick Children (SickKids), both in Toronto, Canada provides further clues ... more males than females. The scientists discovered that males who ... carry are at high risk of developing ASD. The research ...
... , , , , , ... , AUDIO: When men outnumber women, ... Click here for more information. , , , ... , , , , , , ...
... led by Boston University biomedical engineering researchers has won ... of Health to refine its nanoscale, low-cost, ultra-fast DNA ... for less than $1,000. Developed in the ... grant and led by Boston University Biomedical Engineering Professor ...
Cached Biology News:Link to autism in boys found in missing DNA 2Women: Hope to marry young? Head to Alaska, steer clear of Alabama 2Women: Hope to marry young? Head to Alaska, steer clear of Alabama 3Women: Hope to marry young? Head to Alaska, steer clear of Alabama 4BU team wins $4.1M genome grant 2
BKBeta2 potassium channel Antigen: Fusion protein amino acids 1-41 (N-terminus) and 218-235 (C-terminus) of mouse BKBeta2 Accession Number: Q9CZM9...
POU domain, class 2, transcription factor 2,...
... HEK 293T cell line contains the b-lactamase ... response element (CRE). To obtain the cell ... HEK 293T cells by lentivirus. Subsequent flow ... to forskolin stimulation (Figure 1). The CellSensor ...
activating transcription factor 4 (tax-responsive enhancer element B67),...
Biology Products: